Trial Outcomes & Findings for Treatment of Dysphagia by Using a Synchronized Electrical Stimulation Device (NCT NCT02718963)

NCT ID: NCT02718963

Last Updated: 2020-11-12

Results Overview

Maximal pressure, integral, rise time, and duration in the regions of VP and TB (the time interval over the VP and TB integral). The maximal pressure of low pharynx (LP) (C in supplementary 1), maximal pre-upper esophageal sphincter (UES) pressure (F in supplementary 1), maximal cricopharyngeus (CP) pressure (D in supplementary 1), minimal upper esophageal sphincter (UES) pressure, upper esophageal sphincter (UES) activity time (the interval between pre-upper esophageal sphincter (UES) peak and post-upper esophageal sphincter (UES) peak; G in supplementary 1), and nadir upper esophageal sphincter (UES) pressure duration in the region of upper esophageal sphincter (UES).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

20 participants

Primary outcome timeframe

During the electrical stimulation and electrical stimulation effects of Velopharynx, tongue base, lower pharynx and upper esophageal sphincter

Results posted on

2020-11-12

Participant Flow

There was no significant event in the study after participant enrollment

Participant milestones

Participant milestones
Measure
Control Group
* control group(N=10): who does not have dysphagia symptom * apply Synchronized Electrical Stimulation Device * before apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function * during apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function Synchronized Electrical Stimulation Device: electrical stimulation at muscles which related with deglutition
Experimental Group
* experimental group(N=10): who have dysphagia symptoms * apply Synchronized Electrical Stimulation Device * before apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function * during apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function Synchronized Electrical Stimulation Device: electrical stimulation at muscles which related with deglutition
Overall Study
STARTED
10
10
Overall Study
COMPLETED
9
9
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control Group
n=10 Participants
* control group(N=10): who does not have dysphagia symptom * apply Synchronized Electrical Stimulation Device * before apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function * during apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function Synchronized Electrical Stimulation Device: electrical stimulation at muscles which related with deglutition
Experimental Group
n=10 Participants
* experimental group(N=10): who have dysphagia symptoms * apply Synchronized Electrical Stimulation Device * before apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function * during apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function Synchronized Electrical Stimulation Device: electrical stimulation at muscles which related with deglutition
Total
n=20 Participants
Total of all reporting groups
Age, Continuous
51.6 years
STANDARD_DEVIATION 11.99 • n=10 Participants
65.9 years
STANDARD_DEVIATION 13.06 • n=10 Participants
58.75 years
STANDARD_DEVIATION 12.5 • n=20 Participants
Sex: Female, Male
Female
4 Participants
n=10 Participants
2 Participants
n=10 Participants
6 Participants
n=20 Participants
Sex: Female, Male
Male
6 Participants
n=10 Participants
8 Participants
n=10 Participants
14 Participants
n=20 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
South Korea
10 participants
n=10 Participants
10 participants
n=10 Participants
20 participants
n=20 Participants
Disease
Stroke
0 Participants
n=10 Participants
4 Participants
n=10 Participants
4 Participants
n=20 Participants
Disease
Brain tumor
0 Participants
n=10 Participants
1 Participants
n=10 Participants
1 Participants
n=20 Participants
Disease
Cerebral palsy
0 Participants
n=10 Participants
1 Participants
n=10 Participants
1 Participants
n=20 Participants
Disease
Guillain-Barre syndrome
0 Participants
n=10 Participants
1 Participants
n=10 Participants
1 Participants
n=20 Participants
Disease
Spinal cord injury
0 Participants
n=10 Participants
1 Participants
n=10 Participants
1 Participants
n=20 Participants
Disease
Unknown
0 Participants
n=10 Participants
2 Participants
n=10 Participants
2 Participants
n=20 Participants
Disease
Healthy
10 Participants
n=10 Participants
0 Participants
n=10 Participants
10 Participants
n=20 Participants

PRIMARY outcome

Timeframe: During the electrical stimulation and electrical stimulation effects of Velopharynx, tongue base, lower pharynx and upper esophageal sphincter

Maximal pressure, integral, rise time, and duration in the regions of VP and TB (the time interval over the VP and TB integral). The maximal pressure of low pharynx (LP) (C in supplementary 1), maximal pre-upper esophageal sphincter (UES) pressure (F in supplementary 1), maximal cricopharyngeus (CP) pressure (D in supplementary 1), minimal upper esophageal sphincter (UES) pressure, upper esophageal sphincter (UES) activity time (the interval between pre-upper esophageal sphincter (UES) peak and post-upper esophageal sphincter (UES) peak; G in supplementary 1), and nadir upper esophageal sphincter (UES) pressure duration in the region of upper esophageal sphincter (UES).

Outcome measures

Outcome measures
Measure
Control Group
n=10 Participants
* control group(N=10): who does not have dysphagia symptom * apply Synchronized Electrical Stimulation Device * before apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function * during apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function Synchronized Electrical Stimulation Device: electrical stimulation at muscles which related with deglutition
Experimental Group
n=10 Participants
* experimental group(N=10): who have dysphagia symptoms * apply Synchronized Electrical Stimulation Device * before apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function * during apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function Synchronized Electrical Stimulation Device: electrical stimulation at muscles which related with deglutition
Pressure and Timing Change of Velopharynx, Tongue Base, Low Pharynx and Upper Esophageal Sphincter.
Control, pressure of VP, thin
162.04 mmHg
Standard Deviation 39.67
129.66 mmHg
Standard Deviation 45.58
Pressure and Timing Change of Velopharynx, Tongue Base, Low Pharynx and Upper Esophageal Sphincter.
NMES, pressure of VP, thin
200.90 mmHg
Standard Deviation 70.61
170.66 mmHg
Standard Deviation 77.10
Pressure and Timing Change of Velopharynx, Tongue Base, Low Pharynx and Upper Esophageal Sphincter.
Control, pressure of tongue base, thick
81.59 mmHg
Standard Deviation 44.51
136.40 mmHg
Standard Deviation 27.20
Pressure and Timing Change of Velopharynx, Tongue Base, Low Pharynx and Upper Esophageal Sphincter.
NMES, pressure of tongue base, thick
109.22 mmHg
Standard Deviation 54.36
151.26 mmHg
Standard Deviation 34.86

Adverse Events

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Experimental Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Ju Seok Ryu

Seoul National University Bundang Hospital, Seoul National University College of Medicine

Phone: 82-31-787-7739

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place